| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.99B | 45.21B | 43.83B | 44.13B | 41.89B | 39.80B |
| Gross Profit | 8.37B | 9.68B | 8.29B | 9.00B | 7.45B | 6.40B |
| EBITDA | 7.97B | 9.41B | 8.01B | 8.93B | 7.51B | 6.69B |
| Net Income | 1.04B | 1.73B | 1.23B | 1.89B | 1.46B | 965.00M |
Balance Sheet | ||||||
| Total Assets | 73.10B | 74.60B | 75.08B | 69.24B | 63.03B | 59.08B |
| Cash, Cash Equivalents and Short-Term Investments | 7.98B | 9.77B | 8.84B | 7.79B | 8.30B | 8.84B |
| Total Debt | 39.34B | 37.55B | 40.97B | 33.90B | 28.65B | 27.26B |
| Total Liabilities | 51.10B | 50.89B | 52.92B | 47.09B | 42.23B | 39.74B |
| Stockholders Equity | 21.82B | 23.51B | 22.40B | 21.96B | 20.33B | 19.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.75B | -3.74B | -3.60B | -952.00M | 1.34B |
| Operating Cash Flow | 0.00 | 4.74B | -585.00M | -180.00M | -14.00M | 4.29B |
| Investing Cash Flow | 0.00 | -946.00M | -4.54B | -3.19B | -1.21B | -2.98B |
| Financing Cash Flow | 0.00 | -2.91B | 6.15B | 2.80B | 398.00M | -588.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥106.85B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
76 Outperform | ¥14.51B | 8.19 | ― | 3.03% | 6.36% | 41.53% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥18.77B | 10.46 | ― | 3.33% | 3.16% | 42.00% | |
57 Neutral | ¥36.46B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
57 Neutral | ¥32.84B | 8.50 | ― | 4.66% | -8.90% | 9.92% |